Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

New drug delays progression of glioma, a deadly brain cancer

Written by | 7 Jun 2023

In an international study co-led by UCLA, scientists have shown that a new targeted therapy drug can extend the amount of time people with a subtype of glioma… read more.

Ketamine nasal spray may prove safe and effective treatment for refractory migraine

Written by | 3 Jun 2023

Ketamine taken in the form of a nasal spray may prove a safe and effective treatment for refractory chronic migraine, suggests a single centre study, published in the… read more.

Drug significantly reduces chorea symptoms in patients with Huntington’s disease

Written by | 23 May 2023

The drug valbenazine statistically improves chorea, a movement disorder commonly associated with Huntington’s disease, when compared to a placebo, according to a recent international study led by UTHealth Houston researcher… read more.

Atogepant shows efficacy for prevention of migraine

Written by | 14 May 2023

Atogepant, an oral drug approved in the US for the prevention of episodic migraine treatment appears to also be effective for the prevention of chronic migraine. The findings of… read more.

Almost half of people with concussion still show symptoms of brain injury six months later

Written by | 27 Apr 2023

Even mild concussion can cause long-lasting effects to the brain, according to researchers at the University of Cambridge. Using data from a Europe-wide study, the team has shown… read more.

Diabetes drug shows promise for “blinding headache” condition

Written by | 23 Apr 2023

Exenatide, an injectable treatment for type 2 diabetes, has shown efficacy for the treatment of ‘blinding’ headaches known as idiopathic intercranial hypertension (IIH). Researchers from a phase 2… read more.

Is bone health linked to brain health?

Written by | 29 Mar 2023

People who have low bone density may have an increased risk of developing dementia compared to people who have higher bone density, according to a study published in… read more.

New drug to lower brain pressure could treat blinding IIH headaches, trial finds

Written by | 15 Mar 2023

Patients with ‘blinding’ headaches known as Idiopathic Intercranial Hypertension (IIH) could be treated with an injectable peptide used for type 2 diabetes, a new trial has found. The… read more.

Why migraine frequently occurs during menstruation

Written by | 25 Feb 2023

When women suffer migraine attacks, it is often just before or during their monthly period. A team of researchers from Charité – Universitätsmedizin Berlin has now identified a… read more.

Diabetes drug appears to help prevent dementia

Written by | 19 Feb 2023

New research shows that patients with newly diagnosed type 2 diabetes who received treatment with the diabetes drug pioglitazone were less likely to go on to develop dementia… read more.

Study finds video game playing causes no harm to young children’s cognitive abilities

Written by | 11 Feb 2023

Parents: It might be time to rethink your family’s video-gaming rules. New research findings challenge the fears parents have been hearing for years that children who spend hour… read more.

Social isolation linked to neurodegeneration

Written by | 6 Feb 2023

Social lifestyle determinants, including social isolation, are associated with neurodegeneration risk factors, according to a new study published PLOS ONE by scientists at McGill University, Canada. Alzheimer’s disease (AD) is… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.